Clostridioides Difficile Infection Symposium for Patients, Families, Caregivers
This event will be a free, virtual event in July with expert speakers and survivors.
Using Retired Infection Preventionists to Address Staffing Shortages
The organizations and their full-time employees both benefited from the PRN IPs.
Scynexis Announces Launch Plans for Ibrexafungerp
The newly approved therapy will use the brand name, Brexafemme, and is a one-day, novel, oral treatment for vaginal yeast infection.
Decreasing Ventilator-Associated Pneumonia With Novel Oral Care Program
A significant decrease in the rate of VAP occurred during the study period.
Guiding Antibiotic Stewardship Programs in an Outpatient Setting
Post-intervention saw 55% of patients receive overall guideline-concordant antibiotics.
A Case of Mycobacterium Chimaera Infective Endocarditis
Nonspecific, nondolent symptoms make this disease difficult to diagnose.
CoronaVac Safe, Triggers Strong Antibody Response in Children and Adolescents
The Sinovac developed vaccine generated antibodies against SARS-CoV-2 in a phase 1/2 trial.
Tracking Hand Hygiene in a Hospital Setting
Sensors provided data for more hand washing opportunities for healthcare workers and affected related behaviors.
Benefits of a Continuously Active Disinfectant Against Coronavirus 229E
The CAD demonstrated excellent sustained antiviral activity against the test pathogen.
Evaluating an Antibiotic Stewardship Collaborative in New York State Hospitals
Average annual discharges were significantly higher in participating hospitals.
Identifying Employee COVID-19 Risk Factors With Contact Tracing
Communal gathering areas were found to be a major source of exposure.
Clostridioides difficile Infection: Diagnosis, Testing, Screening, and Treatment
Investigators apply guidelines into practical management strategies.
Majority of Young People Who Test Positive for COVID-19 Don’t Require Hospitalization
During the pandemic, one regional health system looked at the age distribution of the virus and hospitalization and mortality rates.
AstraZeneca COVID-19 Vaccine Safe for People with HIV on ART
AstraZeneca’s COVID-19 vaccine was safe and immunogenic for people with HIV who are well-controlled on antiretroviral therapy, a study has shown.
Public Health Watch: A Warning System for the COVID-19 Hospital “Hurricane”
New model uses syndromic surveillance to predict admissions related to SARS-CoV-2.
Ivermectin to be Analyzed in UK Trial as Possible Covid-19 Treatment
The therapy is known to exhibit antiviral properties and reduce SARS-CoV-2 replication in laboratory studies.
Can mRNA COVID-19 Vaccines Be Co-Administered with Flu Shots?
Seqirus is seeking reactogenicity and immunogenicity outcomes between its influenza vaccines and available mRNA vaccines for COVID-19.
The Benefit of COVID-19 & Flu Vaccine Co-Administration
Plus: how could the COVID-19 testing market boom improve public flu awareness?
Tree Pollen May Help to Carry, Spread SARS-CoV-2 Particles
Recommendations based on local pollen levels may help manage infection risk.
How Do You Measure the Success of Your Stewardship Program?
The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.
Awareness for Global Adverse Events for COVID-19 Vaccines
As many vaccines are under Emergency Use Authorization (EUA), understanding the incidence rates of adverse events is critical to providing education and awareness, while working to increase distribution.
Questions Linger Around COVID-19’s Origin
A preview of our August 2021 issue Chairman’s Letter.
IDSA, SHEA Announce New Clostridioides Difficile Clinical Guidelines
The organizations set out 3 recommendations for initial and recurrent C diff treatment.
Co-Administration of COVID-19, Flu Vaccine Yields Promising Results
An interview with a study author on new Novavax-Seqirus co-administration trial data, and the future concerns of circulating COIVD-19 and influenza.
Mutation of Delta Variant Concerning Global Experts
Delta Plus is very similar to the Delta variant with 1 additional mutation.
FDA Working Towards Warning for MRNA COVID-19 Vaccines
With a small number of heart-related adverse effects in younger people, the US Food and Drug Administration (FDA) will move towards a warning statement for Pfizer and Moderna vaccines.
Long-Acting Antiretroviral Therapies for HIV Treatment and Prevention
More treatment options and modalities are now available for patients.
PCR Testing Program Finds Breakthrough COVID-19 Cases Among Vaccinated Passengers
A new report from a Qatari pilot program showed vaccines are highly effective against COVID-19, but they do not completely eliminate risk.
ACIP Provides Recommendations for mRNA COVID-19 Vaccines in Adolescents and Young Adults
The benefits of mRNA vaccinations were determined to still clearly outweigh the risks in adolescents and young adults.
Nebulizers Linked to Environmental Bacterial Contamination
New ASM data show indoor environments are associated with quick and frequent pathogen contamination of the common respiratory device.
